Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$655M |
| 2 |
Coty
COTY
|
+$380M |
| 3 |
ConocoPhillips
COP
|
+$250M |
| 4 |
Zimmer Biomet
ZBH
|
+$213M |
| 5 |
Valero Energy
VLO
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$523M |
| 2 |
Merck
MRK
|
+$375M |
| 3 |
SHPG
Shire pic
SHPG
|
+$362M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$310M |
| 5 |
CELG
Celgene Corp
CELG
|
+$286M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.57% |
| 2 | Technology | 12.05% |
| 3 | Financials | 10.74% |
| 4 | Consumer Discretionary | 9.44% |
| 5 | Energy | 8.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Humana
HUM
$45.5B
| $42.4M | 0.06% |
159,220
-343,846
| -68% | -$99.1M |
|
402
RingCentral
RNG
$5.6B
| $42.1M | 0.06% |
390,262
-435,894
| -53% | -$42.8M |
|
403
United Rentals
URI
$68.4B
| $42.1M | 0.06% |
368,228
+73,465
| +25% | +$9.07M |
|
404
Brighthouse Financial
BHF
$3.01B
| $41.9M | 0.06% |
1,153,335
+1,137,189
| +7,043% | +$42.6M |
|
405
Sherwin-Williams
SHW
$84.1B
| $41.8M | 0.06% |
291,459
-1,136,874
| -80% | -$158M |
|
406
Puma Biotechnology
PBYI
$477M
| $41.8M | 0.06% |
1,078,404
-254,292
| -19% | -$7.77M |
|
407
Iron Mountain
IRM
$36.3B
| $41.8M | 0.06% |
1,179,287
+1,166,635
| +9,221% | +$41.2M |
|
|
RETA
408
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $41.8M | 0.06% |
488,925
+353,267
| +260% | +$29.3M |
|
409
Bio-Techne
TECH
$11.3B
| $41.7M | 0.06% |
840,124
+826,876
| +6,242% | +$37.2M |
|
410
Pacira BioSciences
PCRX
$983M
| $41.6M | 0.06% |
1,093,703
-130,811
| -11% | -$5.11M |
|
411
NiSource
NI
$19.5B
| $41.6M | 0.06% |
1,451,714
-4,058,269
| -74% | -$109M |
|
412
Carter's
CRI
$1.31B
| $41.6M | 0.06% |
412,374
-284,812
| -41% | -$25.4M |
|
413
CALL
iShares MSCI Emerging Markets ETF
EEM
$31.2B
| $41.5M | 0.06% |
967,200
-1,106,000
| -53% | -$46.5M |
|
414
Newell Brands
NWL
$2.59B
| $41.3M | 0.06% |
2,692,796
-1,088,682
| -29% | -$20M |
|
|
ABMD
415
DELISTED
Abiomed Inc
ABMD
| $41.1M | 0.06% |
143,995
+73,787
| +105% | +$24.5M |
|
416
Popular Inc
BPOP
$10.8B
| $40.8M | 0.06% |
782,515
-505,833
| -39% | -$26.9M |
|
|
ZNGA
417
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $40.6M | 0.06% |
7,611,026
-109,766
| -1% | -$528K |
|
418
Fortinet
FTNT
$113B
| $40.5M | 0.06% |
2,409,455
-6,036,320
| -71% | -$96.2M |
|
419
Corpay
CPAY
$27.4B
| $40.5M | 0.06% |
164,063
+15,953
| +11% | +$3.45M |
|
420
Tyler Technologies
TYL
$14.4B
| $40.4M | 0.06% |
197,808
+190,254
| +2,519% | +$37.7M |
|
421
UDR
UDR
$12.1B
| $40.3M | 0.06% |
886,627
+77,992
| +10% | +$3.39M |
|
|
FLIR
422
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $40.3M | 0.06% |
847,113
+350,804
| +71% | +$17M |
|
423
Cousins Properties
CUZ
$4.89B
| $40.3M | 0.06% |
1,042,471
+776,953
| +293% | +$28.4M |
|
424
Cannae Holdings
CNNE
$672M
| $40.3M | 0.06% |
1,659,753
+1,314,537
| +381% | +$27.7M |
|
|
RP
425
DELISTED
RealPage, Inc.
RP
| $40.2M | 0.06% |
663,042
+265,692
| +67% | +$15.2M |
|
Similar funds
Israel Englander's Q1 2019 Portfolio in Review
As of Q1 2019, Israel Englander held 4,608 positions worth $66.8B, up 4.2% from $64.1B the previous quarter. Its ten largest holdings account for 7.1% of the portfolio.
Israel Englander withdrew a net $6.14B in Q1 2019, closing 675 positions and reducing 1,467 holdings. Its most notable exit was Merck, an estimated $375M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 14% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Zimmer Biomet worth $232M.
- Israel Englander's largest Q1 2019 buy was Zimmer Biomet: 1,870,503 shares worth $232M.
- Israel Englander added most to Walt Disney in Q1 2019, an estimated $655M increase.
- Israel Englander's biggest Q1 2019 reduction was Apple, cutting an estimated $523M.
- Israel Englander fully exited Merck in Q1 2019, selling an estimated $375M.
- Israel Englander's ten largest holdings make up 7.1% of its $66.8B portfolio in Q1 2019.
- Israel Englander opened 914 new positions and closed 675 in Q1 2019.
- Israel Englander's portfolio value rose 4.2% quarter-over-quarter to $66.8B.
Based on Millennium Management's 13F filing for Q1 2019, filed 14 May 2019.